• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】32841

【品名】4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid

【CA登记号】14047-29-1

【 分 子 式 】C7H7BO4

【 分 子 量 】165.94118

【元素组成】C 50.67% H 4.25% B 6.51% O 38.57%

与该中间体有关的原料药合成路线共 7 条

合成路线1

该中间体在本合成路线中的序号:(IX)

Palladium-catalyzed coupling of phenyloxadiazol derivative (VIII) with 4-boronobenzoic acid (IX) yielded biphenyl (X). Further treatment of (X) with SOCl2 afforded acid chloride (XI). This was finally condensed with amine (VII) to provide the title carboxamide.

1 Gaster, L.M.; King, F.D.; Wyman, P.A. (GlaxoSmithKline plc); Tetracyclic spiro cpds., process for their preparation and their use as 5HT1D receptor antagonists. EP 0799226; JP 1998510821; US 5972951; WO 9619477 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII) 32844 1'-Ethyl-3,5,6,7-tetrahydro-2H-spiro[furo[2,3-f]indole-3,4'-piperidine] C16H22N2O 详情 详情
(VIII) 32840 2-(4-bromo-3-methylphenyl)-5-methyl-1,3,4-oxadiazole C10H9BrN2O 详情 详情
(IX) 32841 4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid 14047-29-1 C7H7BO4 详情 详情
(X) 32842 2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-4-carboxylic acid C17H14N2O3 详情 详情
(XII) 32843 2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-4-carbonyl chloride C17H13ClN2O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VIII)

Bromination of 2-amino-5-methylpyrazine (I) with Br2 in CHCl3 affords the bromopyrazine (II). Subsequent bromide displacement in (II) by means of sodium methoxide gives rise to the methoxypyrazine (III). The amino group of (III) is then protected by acylation with isobutyl chloroformate, to produce carbamate (IV). Diazotization of 3-amino-2-chloropyridine (V), followed by treatment with sulfur dioxide in the presence of CuCl furnishes sulfonyl chloride (VI). Carbamate (IV) is then acylated by means of NaH and sulfonyl chloride (VI) in DMF to furnish the N-sulfonyl carbamate (VII). Esterification of 4-carboxyphenylboronic acid (VIII) with H2SO4 in MeOH gives 4-(methoxycarbonyl)phenylboronic acid (IX). Mitsunobu coupling between boronic acid (IX) and chloropyridine (VII) furnishes adduct (X). Methyl ester (X) is converted into hydrazide (XI) by treatment with hydrazine hydrate in refluxing methanol. Then, cyclization of the acyl hydrazide (XI) with boiling triethyl orthoformate gives rise to the target oxadiazole derivative.

1 Bradbury, R.H.; Butlin, R.J.; James, R. (AstraZeneca plc); N-Heteroaryl-pyridinesulfonamide derivs. and their use as endothelin antagonists. EP 0832082; JP 1999509175; US 6060475; US 6258817; WO 9640681 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 64109 5-methyl-2-pyrazinamine; 5-methyl-2-pyrazinylamine C5H7N3 详情 详情
(II) 64110 3-bromo-5-methyl-2-pyrazinamine; 3-bromo-5-methyl-2-pyrazinylamine C5H6BrN3 详情 详情
(III) 64111 5-methyl-3-(methyloxy)-2-pyrazinamine; 5-methyl-3-(methyloxy)-2-pyrazinylamine C6H9N3O 详情 详情
(IV) 64112 2-methylpropyl 5-methyl-3-(methyloxy)-2-pyrazinylcarbamate C11H17N3O3 详情 详情
(V) 11160 2-Chloro-3-pyridinamine; 2-Chloro-3-pyridinylamine; 3-Amino-2-chloropyridine; 2-Chloro-3-aminopyridine 6298-19-7 C5H5ClN2 详情 详情
(VI) 64113 2-chloro-3-pyridinesulfonyl chloride C5H3Cl2NO2S 详情 详情
(VII) 64115 2-methylpropyl (2-chloro-3-pyridinyl)sulfonyl[5-methyl-3-(methyloxy)-2-pyrazinyl]carbamate C16H19ClN4O5S 详情 详情
(VIII) 32841 4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid 14047-29-1 C7H7BO4 详情 详情
(IX) 64114 4-[(methyloxy)carbonyl]phenylboronic acid C8H9BO4 详情 详情
(X) 64116 methyl 4-{3-[([5-methyl-3-(methyloxy)-2-pyrazinyl]{[(2-methylpropyl)oxy]carbonyl}amino)sulfonyl]-2-pyridinyl}benzoate C24H26N4O7S 详情 详情
(XI) 64117 2-[4-(hydrazinocarbonyl)phenyl]-N-[5-methyl-3-(methyloxy)-2-pyrazinyl]-3-pyridinesulfonamide C18H18N6O4S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VII)

Reaction of 3-(cyanomethyl)pyridine-N-oxide (I) with cyanotrimethylsilane and dimethylcarbamoyl chloride provided dinitrile (II). Subsequent cyclization of (II) in the presence of HBr gave rise to 6-amino-8-bromo-1,7-naphthyridine (III). Attachment of a 3-nitrophenyl group to (III) to afford (V) was carried out by Suzuki coupling of (III) with 3-nitrophenylboronic acid (IV) in the presence of bis(dibenzylideneacetone)palladium and triphenylphosphine. The required triflate (VI) was then obtained by nitrosation of aminonaphthyridine (V) in trifluromethanesulfonic acid/DMF. Finally, a second Suzuki coupling of (VI) with 4-carboxyphenylboronic acid (VII) provided the title 6,8-diarylnaphthyridine.

1 Bray-French, K.; Hersperger, R.; Müller, T.; Mazzoni, L.; Palladium-catalyzed cross-coupling reactions for the synthesis of 6,8-disubstituted 1,7-naphthyridines: A novel class of potent and selective phosphodiesterase type 4D inhibitors. J Med Chem 2000, 43, 4, 675.
2 Hersperger, R. (Novartis AG); Naphtyridine derivs.. EP 0934320; US 6136821; WO 9818796 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 40931 3-(cyanomethyl)-1-pyridiniumolate C7H6N2O 详情 详情
(II) 40932 3-(cyanomethyl)-2-pyridinecarbonitrile C8H5N3 详情 详情
(III) 40933 8-bromo[1,7]naphthyridin-6-ylamine; 8-bromo[1,7]naphthyridin-6-amine C8H6BrN3 详情 详情
(IV) 40934 3-nitrophenylboronic acid 13331-27-6 C6H6BNO4 详情 详情
(V) 40935 8-(3-nitrophenyl)[1,7]naphthyridin-6-ylamine; 8-(3-nitrophenyl)[1,7]naphthyridin-6-amine C14H10N4O2 详情 详情
(VI) 40936 8-(3-nitrophenyl)[1,7]naphthyridin-6-yl trifluoromethanesulfonate C15H8F3N3O5S 详情 详情
(VII) 32841 4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid 14047-29-1 C7H7BO4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(XI)

3-(Cyanomethyl)pyridine-N-oxide (VI) was converted to the pyridine dinitrile (VII) by treatment with cyanotrimethylsilane and dimethylcarbamoyl chloride. Cyclization of dinitrile (VII) in the presence of HBr gave rise to 6-amino-8-bromo-1,7-naphthyridine (VIII). Attachment of the benzofurazanyl moiety to (VIII) was performed by Suzuki coupling with boronic acid (V) in the presence of bis(dibenzylideneacetone)palladium and tri(o-tolyl)phosphine. The resultant 6 amino-8-aryl naphthyridine (IX) was subjected to diazotization in the presence of trifluoromethanesulfonic acid to furnish triflate (X). Further Suzuki coupling of triflate (X) with 4-carboxyphenylboronic acid (XI) led to the title compound.

1 Hersperger, R.; Dawson, J.; Mueller, T.; Synthesis of 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridine-6-yl)-benzoic acid: A potent and selective phosphodiesterase type 4D inhibitor. Bioorg Med Chem Lett 2002, 12, 2, 233.
2 Hersperger, R. (Novartis AG); Naphtyridine derivs.. EP 0934320; US 6136821; WO 9818796 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 59799 2,1,3-benzoxadiazol-5-ylboronic acid C6H5BN2O3 详情 详情
(VI) 40931 3-(cyanomethyl)-1-pyridiniumolate C7H6N2O 详情 详情
(VII) 40932 3-(cyanomethyl)-2-pyridinecarbonitrile C8H5N3 详情 详情
(VIII) 40933 8-bromo[1,7]naphthyridin-6-ylamine; 8-bromo[1,7]naphthyridin-6-amine C8H6BrN3 详情 详情
(IX) 59906 8-(2,1,3-benzoxadiazol-5-yl)[1,7]naphthyridin-6-amine; 8-(2,1,3-benzoxadiazol-5-yl)[1,7]naphthyridin-6-ylamine C14H9N5O 详情 详情
(X) 59907 8-(2,1,3-benzoxadiazol-5-yl)[1,7]naphthyridin-6-yl trifluoromethanesulfonate C15H7F3N4O4S 详情 详情
(XI) 32841 4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid 14047-29-1 C7H7BO4 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XI)

In an alternative synthetic procedure, dinitrile (VII) was cyclized in the presence of sodium methoxide to produce 6-amino-8-methoxy-1,7-naphthyridine (XII). This was converted to triflate (XIII) by diazotization in the presence of trifluoromethanesulfonic acid. Suzuki coupling of triflate (XIII) with 4 carboxyphenylboronic acid (XI) yielded adduct (XIV). The 8-methoxy group of (XIV) was then displaced with PBr3 to produce bromide (XV), which was subjected to further Suzuki coupling with the benzofurazan boronic acid (V) to provide the title compound.

1 Hersperger, R.; Dawson, J.; Mueller, T.; Synthesis of 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridine-6-yl)-benzoic acid: A potent and selective phosphodiesterase type 4D inhibitor. Bioorg Med Chem Lett 2002, 12, 2, 233.
2 Hersperger, R. (Novartis AG); Naphtyridine derivs.. EP 0934320; US 6136821; WO 9818796 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 59799 2,1,3-benzoxadiazol-5-ylboronic acid C6H5BN2O3 详情 详情
(VII) 40932 3-(cyanomethyl)-2-pyridinecarbonitrile C8H5N3 详情 详情
(XI) 32841 4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid 14047-29-1 C7H7BO4 详情 详情
(XII) 59909 8-methoxy[1,7]naphthyridin-6-amine; 8-methoxy[1,7]naphthyridin-6-ylamine C9H9N3O 详情 详情
(XIII) 59910 8-methoxy[1,7]naphthyridin-6-yl trifluoromethanesulfonate C10H7F3N2O4S 详情 详情
(XIV) 59911 4-(8-methoxy[1,7]naphthyridin-6-yl)benzoic acid C16H12N2O3 详情 详情
(XV) 59912 4-(8-bromo[1,7]naphthyridin-6-yl)benzoic acid C15H9BrN2O2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(VII)

 

1 Duffy KJ, Erickson-Miller CL, Eppley DF, et al.2001. Thrombopoietin mimetics. WO 2001089457
2 Moore S. 2003. Preparation of (pyrazolidenehydrazino) [1,1'-biphenyl]-3-carboxylates as TPO receptor agonists for enhancing platelet prodn. WO 2003098992.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20704 3-bromophenol 591-20-8 C6H5BrO 详情 详情
(II) 67115 2-Nitro-5-bromophenol;3-Bromo-6-nitrophenol;5-Bromo-2-nitrophenol 27684-84-0 C6H4BrNO3 详情 详情
(III) 67116 3'-hydroxy-4'-nitro-[1,1'-biphenyl]-4-carboxylic acid   C13H9NO5 详情 详情
(IV) 67117 4'-amino-3'-hydroxy-[1,1'-biphenyl]-4-carboxylic acid   C13H11NO3 详情 详情
(V) 67118 1-(3,4-dimethylphenyl)-3-methyl-1H-pyrazol-5(4H)-one 18048-64-1 C12H14N2O 详情 详情
(VI) 67119 3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid 496775-61-2 C25H22N4O4 详情 详情
(VII) 32841 4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid 14047-29-1 C7H7BO4 详情 详情

合成路线7

该中间体在本合成路线中的序号:(VI)

In one strategy, condensation of 4-bromobenzohydrazide (I) with HC(OEt)3 in the presence of H2SO4 in refluxing methylated spirit gives 2-(4-bromophenyl)-1,3,4-oxadiazole (II), which upon treatment with (i-PrO)3B in the presence of MeLi and BuLi in THF at –65 °C affords the boronic acid derivative (III). Suzuki coupling between the boronic acid (III) and the chloropyridine derivative (IV) in the presence of Pd(OAc)2, 3,3′,3′′-phosphinidynetris(benzenesulfonic acid) trisodium salt (TPPTS) and NMM in H2O/i-PrOH at 83 °C affords N-protected zibotentan (V). Finally, intermediate (V) is deprotected with ethanolamine in H2O/i-PrOH at 42 °C or with NH3 in H2O/methylated spirit at 60 °C and acidified with AcOH in H2O .
In a second strategy, 4-carboxyphenylboronic acid (VI) is esterified with MeOH in the presence of H2SO4, yielding boronic acid (VII), which undergoes Suzuki coupling with the chloropyridine derivative (IV) in the presence of Pd(PPh3)4 and KF in refluxing toluene/H2O to provide adduct (VIII). Finally, methyl ester (VIII) is converted to hydrazide (IX) by treatment with hydrazine hydrate in refluxing methanol and cyclized by condensation with refluxing HC(OEt)3 .

1 Brear, C., Hogan, P., Montgomery, F. (AstraZeneca AB). Ethanolamine salt of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazole-2-yl]phenyl) pyridine3-sulphonamide. WO 2007010235.
2 Bradbury, R.H., Butlin, R.J., James, R. (AstraZeneca plc). N-Heteroarylpyridinesulfonamide derivatives and their use as endothelin antagonists. EP 0832082, JP 1999509175, US 6060475, US 6258817, WO 1996040681.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 69326 4-bromobenzohydrazide;(4-Bromobenzoyl)hydrazine;(p-Bromobenzoyl)hydrazine;4-Bromobenzenecarboxylic acid hydrazide;4-Bromobenzhydrazide;4-Bromobenzohydrazide;4-Bromobenzoic acid hydrazide;4-Bromobenzoic hydrazide;4-Bromobenzoyl hydrazide;INHd 16;NSC 60114;p-Bromobenzhydrazide;p-Bromobenzoic acid hydrazide;p-Bromobenzoic hydrazide 5933-32-4 C7H7BrN2O 详情 详情
(II) 69327 2-(4-bromophenyl)-1,3,4-oxadiazole;2-(4-bromophenyl)-1,3,4-oxadiazole C8H5BrN2O 详情 详情
(III) 69328 (4-(1,3,4-oxadiazol-2-yl)phenyl)boronic acid C8H7BN2O3 详情 详情
(IV) 69329 isobutyl (2-chloropyridin-3-yl)sulfonyl(3-methoxy-5-methyl-4,5-dihydropyrazin-2-yl)carbamate C16H21ClN4O5S 详情 详情
(V) 69330 isobutyl (2-(4-(1,3,4-oxadiazol-2-yl)phenyl)pyridin-3-yl)sulfonyl(3-methoxy-5-methylpyrazin-2-yl)carbamate C24H24N6O6S 详情 详情
(VI) 32841 4-(dihydroxyboryl)benzoic acid;4-Boronobenzoic acid;4-carboxyphenylboronic acid;4-(Dihydroxyboryl)benzoic acid 14047-29-1 C7H7BO4 详情 详情
(VII) 64114 4-[(methyloxy)carbonyl]phenylboronic acid C8H9BO4 详情 详情
(VIII) 64116 methyl 4-{3-[([5-methyl-3-(methyloxy)-2-pyrazinyl]{[(2-methylpropyl)oxy]carbonyl}amino)sulfonyl]-2-pyridinyl}benzoate C24H26N4O7S 详情 详情
(IX) 64117 2-[4-(hydrazinocarbonyl)phenyl]-N-[5-methyl-3-(methyloxy)-2-pyrazinyl]-3-pyridinesulfonamide C18H18N6O4S 详情 详情
Extended Information